Stem Cells and Glaucoma

  • Shan Lin
  • Mary Kelley
  • John Samples


Patients frequently ask about the applicability of stem cell research and therapy for their glaucoma. Stem cell therapies do offer significant promise in glaucoma. Like other neuro-degenerative diseases where stem cells may be of benefit, glaucoma offers logical targets for stem cell therapy. For glaucoma, these are the optic nerve and the trabecular meshwork. In Parkinson’s disease, stem cells delivered to the basal ganglia have proven to have significant therapeutic benefit.


Stem Cell Optic Nerve Retinal Ganglion Cell Stem Cell Therapy Stem Cell Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Svensen C. Stem cells and Parkinsons disease: toward a treatment not a cure. Stem Cell. 2008;2(5):412-413. PubMed ID: 18462691.CrossRefGoogle Scholar
  2. 2.
    Jones CA, London NR, Chen H, et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med. 2008;14(4):448-453. PubMed ID: 18345009.CrossRefPubMedGoogle Scholar
  3. 3.
    Kelley MJ, Rose AY, Keller KE, Hessle H, Samples JR, Acott TS. Stem cells in the trabecular meshwork: present and future promises. Exp Eye Res. 2009;88:747–751.CrossRefPubMedGoogle Scholar
  4. 4.
    Zhang CC, Lodish HF. Cytokines regulating hematopoietic stem cell function. Curr Opin Hematol. 2008;14(4):307–311.CrossRefGoogle Scholar
  5. 5.
    Loveland KL, Hogarth C, Mendis S, et al. Drivers of germ cell maturation. Ann N Y Acad Sci. 2005;1061:173-182. Review.CrossRefPubMedGoogle Scholar
  6. 6.
    Heng BC, Cao T, Lee EH. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells. 2004;22(7):1152-1167. Review.CrossRefPubMedGoogle Scholar
  7. 7.
    Sachinidis A, Fleischmann BK, Kolossov E, Wartenberg M, Sauer H, Hescheler J. Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res. 2003;58(2):278-291. Review.CrossRefPubMedGoogle Scholar
  8. 8.
    Rosenbaum JT, Howes EL, Rubin RM, Samples JR. Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. Am J Pathol. 1998;133:47–53.Google Scholar
  9. 9.
    Rosenbaum JT, Samples JR, Hefeneider SH, Howes EL Jr. Ocular inflammatory effects of intravitreal interleukin-1. Arch Ophthalmol. 1987;105:1117–1120.PubMedGoogle Scholar
  10. 10.
    Acott TS, Kingsley PD, Samples JR, Van Buskirk EM. Human trabecular meshwork organ culture: morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci. 1988;29:90–100.PubMedGoogle Scholar
  11. 11.
    Fuchshofer R, Welge-Lussen U, Lütjen-Drecoll E. The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp Eye Res. 2003;77:757–765.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Shan Lin
    • 1
  • Mary Kelley
    • 2
  • John Samples
    • 3
    • 4
    • 5
  1. 1.Department of OphthalmologyUniversity of California San Francisco, School of MedicineSan FranciscoUSA
  2. 2.Department of OphthalmologyCasey Eye Institute, Oregon Health and Science UniversityPortlandUSA
  3. 3.Oregon Health and Sciences UniversityPortlandUSA
  4. 4.Rocky Vista UniversityParkerUSA
  5. 5.Pacific Coast Oto-Ophthalmology Society Specialty Eye CareParkerUSA

Personalised recommendations